Key Points

  • Robinhood (HOOD) beat Wall Street estimates with earnings per share of $0.61, up 259% year-over-year, and total revenue rising 100% to $1.27 billion.
  • The company’s crypto transaction revenue jumped over 300%, while equities revenue climbed 132%.
  • Despite strong results, shares fell slightly in after-hours trading, as investors weigh sustainability of growth after a 280% year-to-date rally.
hero

Robinhood Markets Inc. (HOOD) delivered another standout quarter, smashing Wall Street expectations as a surge in cryptocurrency trading and new product innovation pushed revenue and profit sharply higher. Yet, the stock dipped over 1% in postmarket trading Wednesday, signaling investor caution after a parabolic run that has made the retail brokerage one of the top-performing stocks in the S&P 500 this year.

Record Earnings Driven by Crypto and New Revenue Streams

The Menlo Park-based brokerage reported earnings per share of $0.61, beating the consensus estimate of $0.53 and representing a 259% year-over-year increase. Total revenue doubled from a year ago to $1.27 billion, comfortably ahead of Wall Street’s $1.2 billion forecast.

The standout driver was Robinhood’s crypto transaction revenue, which surged over 300% year-over-year amid a resurgence in digital asset trading. The platform’s equities transaction revenue also soared 132%, underscoring renewed retail participation in both traditional and digital markets.

CEO Vlad Tenev credited the company’s strong results to its “relentless product velocity,” citing rapid user adoption of new services. “Prediction Markets are growing rapidly, Robinhood Banking is starting to roll out, and Robinhood Ventures is coming,” Tenev said in the company’s earnings release.

Robinhood’s aggressive push into tokenized assets, crypto staking, and event-based trading has set it apart from traditional brokerages, transforming the company into a hybrid fintech platform bridging traditional finance and blockchain innovation.

Crypto and Prediction Markets Fuel Momentum

The surge in crypto activity has been a critical driver of Robinhood’s turnaround after a prolonged slump in trading volumes through 2022 and early 2023. Analysts say the recovery in Bitcoin and other digital assets has reignited retail interest, while the company’s expansion into European markets with tokenized stock trading has opened up new revenue channels.

Robinhood’s Prediction Markets, launched earlier this year, have also been a breakout success. The service allows users to wager on real-world events — from major sports outcomes to macroeconomic data, corporate earnings, and even political developments.

According to Compass Point analyst Ed Engel, these markets could prove a key revenue engine moving forward. “We forecast HOOD generating roughly $20 million in revenue from prediction markets in Q3, which is up over 100% quarter-over-quarter,” Engel noted in a recent client note. He added that October trends appear “well above fourth-quarter expectations,” suggesting the company’s growth momentum is accelerating into year-end.

EY blockchain leader Paul Brody said the company’s integrated approach to new financial products is setting an industry standard: “I see lots of companies copying from Robinhood—offering additional services, integrating them together in a very nice user experience, and delivering them to their end customers.”

Market Reaction and Forward-Looking Outlook

Despite the stellar results, Robinhood’s shares slipped 1% in after-hours trading, a modest pullback after an extraordinary rally that has seen the stock surge 280% year-to-date and nearly 40% since joining the S&P 500 in September.

The muted reaction may reflect investor concern about whether Robinhood can maintain such torrid growth. With markets volatile and crypto prices fluctuating sharply, sustaining transaction volumes into 2026 could prove challenging.

Still, analysts remain broadly optimistic. Robinhood’s growing ecosystem — spanning brokerage, crypto, banking, and prediction markets — has positioned it as one of the most diversified fintech platforms in the retail investing landscape. If execution remains strong and user engagement continues to rise, the company could extend its leadership in both traditional and decentralized finance.


Comparison, examination, and analysis between investment houses

Leave your details, and an expert from our team will get back to you as soon as possible

    * This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.

    To read more about the full disclaimer, click here
    SKN | McDonald’s Stock Climbs as U.S. Sales Beat Forecasts, Value Strategy Cushions Slowdown
    • sagi habasov
    • 7 Min Read
    • ago 9 minutes

    SKN | McDonald’s Stock Climbs as U.S. Sales Beat Forecasts, Value Strategy Cushions Slowdown SKN | McDonald’s Stock Climbs as U.S. Sales Beat Forecasts, Value Strategy Cushions Slowdown

      McDonald’s Corp. shares rose on Tuesday after the fast-food giant reported stronger-than-expected U.S. sales, suggesting its value-oriented menu and

    • ago 9 minutes
    • 7 Min Read

      McDonald’s Corp. shares rose on Tuesday after the fast-food giant reported stronger-than-expected U.S. sales, suggesting its value-oriented menu and

    SKN | Has Novo Nordisk’s GLP-1 Boom Peaked? Slowing Demand Raises Questions About Sustainability
    • Ronny Mor
    • 7 Min Read
    • ago 1 hour

    SKN | Has Novo Nordisk’s GLP-1 Boom Peaked? Slowing Demand Raises Questions About Sustainability SKN | Has Novo Nordisk’s GLP-1 Boom Peaked? Slowing Demand Raises Questions About Sustainability

      Novo Nordisk, the Danish pharmaceutical giant behind Wegovy and Ozempic, is facing signs of cooling demand for its GLP-1-based

    • ago 1 hour
    • 7 Min Read

      Novo Nordisk, the Danish pharmaceutical giant behind Wegovy and Ozempic, is facing signs of cooling demand for its GLP-1-based

    SKN | Is Novo Nordisk Losing Its Grip on the Weight-Loss Drug Market?
    • Lior mor
    • 8 Min Read
    • ago 2 hours

    SKN | Is Novo Nordisk Losing Its Grip on the Weight-Loss Drug Market? SKN | Is Novo Nordisk Losing Its Grip on the Weight-Loss Drug Market?

    Shares of Novo Nordisk (NVO) slid further this week after the Danish pharmaceutical giant scaled back its earnings outlook, citing

    • ago 2 hours
    • 8 Min Read

    Shares of Novo Nordisk (NVO) slid further this week after the Danish pharmaceutical giant scaled back its earnings outlook, citing

    SKN | Will Elon Musk Leave Tesla if His $1 Trillion Pay Package Is Rejected?
    • orshu
    • 6 Min Read
    • ago 3 hours

    SKN | Will Elon Musk Leave Tesla if His $1 Trillion Pay Package Is Rejected? SKN | Will Elon Musk Leave Tesla if His $1 Trillion Pay Package Is Rejected?

      Tesla’s leadership stability is once again under the microscope as CEO Elon Musk’s massive compensation package—estimated at over $1

    • ago 3 hours
    • 6 Min Read

      Tesla’s leadership stability is once again under the microscope as CEO Elon Musk’s massive compensation package—estimated at over $1